Damone Thomas,
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from…
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
Overview of attention for article published in The Lancet, July 2013
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (81st percentile)
Mentioned by
- news
- 1 news outlet
- policy
- 3 policy sources
- 8 X users
- 2 Facebook pages
- 2 Redditors
- f1000
- 1 research highlight platform
- guideline
- 5 clinical guideline sources
Readers on
- mendeley
- 452 Mendeley